MedTrace Logo

Is AMPS a Responsive Tool for Assessing Change in ADL-abilities After Finger or Hand Surgery

NCT03496337 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 45

Last updated 2018-12-21

No results posted yet for this study

Summary

The aim of the study is to assess the responsiveness of the Assessment of Motor and Process Skills (AMPS) in a population of patients undergoing rehabilitation following hand surgery, as this has not previously been investigated.

Methods: Patients are included from the department of physical and occupational therapy at Silkeborg Regional Hospital in the period November 2017 to May 2018. A total of 50 patients, who have been referred for specialized occupational therapy rehabilitation following finger or hand surgery, will be included. At baseline and follow-up (after 8 weeks) all patients are assessed with AMPS, Canadian Occupational Performance Measure (COPM), hand grip strength and joint range of motion using standardized methods. Responsiveness to change is evaluated using an anchor-based method, comparing AMPS scores with the scores on the Global Rating Scale. The area under the ROC curve will be calculated, and an area under the curve of 0.7 is considered acceptable. Convergent and discriminative validity of the AMPS will be assessed across the different instruments used. Thus the investigators expect a higher correlation between AMPS and COPM and lower correlation between AMPS and hand grip strength and range of motion.

Conditions

  • Radius Fractures
  • Hand Fracture
  • Hand Injuries

Interventions

OTHER

Assessment of motor and process skills test

At baseline and follow-up (after 8-10 weeks) all patients are assessed with AMPS in addition to the standard test of Canadian Occupational Performance Measure (COPM) hand grip strength and joint range of motion.

Sponsors & Collaborators

  • Central Jutland Regional Hospital

    lead OTHER

Principal Investigators

  • Nanna Rolving, PhD · Regionshospitalet Silkeborg

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-01
Primary Completion
2018-09-01
Completion
2018-09-01

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03496337 on ClinicalTrials.gov